Bioanalysis of Small Molecules & Generics

We are a GLP-certified and GCP compliant multinational CRO with broad experience working with large generics companies in need of full bioequivalence studies and small biotech innovators carrying out basic R&D. We also work with animal health firms to carry out residue depletion studies. Our experienced bioanalysis of small molecules team can support you in these specialist areas:

• Preclinical studies of small molecules
• PK (pharmacokinetics) and PD (pharmacodynamic) calculations and statistics
• Metabolite identification and quantification
• Toxicokinetics
• Biomarkers/Pharmacodynamics
• Clinical studies of small molecules
• Phase I-IV pharmacokinetics including first-in-man dose escalation studies
• Drug-drug interaction studies
• Biomarkers/Pharmacodynamics
• Bioequivalence studies of generics
• Percutaneous absorption
• Residue depletion studies
• Absorption studies